Global Market Presence Moehs Iberica manufactures and sells over 75 pharmaceutical and related products across more than 90 countries, indicating a strong international footprint and potential for expanding distribution channels or partnership opportunities globally.

Accredited Quality Standards The company’s adherence to GMPs, ICH guidelines, and approvals from FDA and TGA highlights a high standard of quality and safety, making it a reliable partner for pharmaceutical companies seeking compliant and high-quality active ingredients.

Recent Facility Expansion The recent addition of a cutting-edge hydrogenation facility in Belgium demonstrates ongoing investment in advanced manufacturing capabilities, creating opportunities for clients requiring complex chemical synthesis and scale-up services.

Industry Recognition Awards such as the Assurance level and Cambra Prize underscore Moehs Iberica’s reputation for operational excellence and innovative business initiatives, fostering trust and potential collaboration with quality-focused partners.

Financial Stability and Growth With revenues ranging from 10 to 25 million dollars and a solid client base, Moehs Iberica presents a stable and scalable opportunity for companies looking to supply or collaborate in high-demand pharmaceutical ingredients or expand their product portfolio.